Adverse effects are uncommon with the use of cisatracurium. Adverse reactions occurred at a rateÂ of less than 1% and include bradycardia, hypotension, bronchospasm, rash, anaphylaxis, prolonged neuromuscular blockade, and myopathy.

No clinically relevant alterations in the recovery profile were observed in patients with renal dysfunction or end-stage liver disease, making cisatracurium a good choice in a patient with either of these diseases.